Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | F9 | P00740 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22273764 | 0.94 | MEN1 (0.38) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22274113 | 0.90 | MEN1 (0.39) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22273750 | 0.89 | MEN1 (0.33) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL24280211 | 0.88 | MEN1 (0.40) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22274116 | 0.88 | ERBB2 (0.33) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22274326 | 0.87 | MEN1 (0.36) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22274333 | 0.85 | MEN1 (0.35) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22273988 | 0.85 | MEN1 (0.38) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL24280526 | 0.85 | MAPT (0.37) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL18859604 | 0.84 | ELANE (0.34) | ALDH1A1MAPTHPGDADORA2APIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220085298-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | LT MATERIALS CO., LTD. (KR) | 2022-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220085298-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | ALDH1A2, OXER1, AOX1 | MEN1 3195/4885KMT2A 3054/4885ALDH1A1 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.